135 related articles for article (PubMed ID: 22528598)
1. The role of combination therapy in type 2 diabetes in the post-ACCORD era.
Kuritzky L
Curr Diab Rep; 2012 Jun; 12(3):227-9. PubMed ID: 22528598
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China.
Gu S; Wang X; Qiao Q; Gao W; Wang J; Dong H
Diabetes Obes Metab; 2017 Dec; 19(12):1688-1697. PubMed ID: 28452095
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
Wang B; Zhong J; Lin H; Zhao Z; Yan Z; He H; Ni Y; Liu D; Zhu Z
Diabetes Obes Metab; 2013 Aug; 15(8):737-49. PubMed ID: 23433305
[TBL] [Abstract][Full Text] [Related]
4. Exenatide in combination therapy: small study, big market, and many unanswered questions.
Malozowski S
Ann Intern Med; 2007 Apr; 146(7):527-8. PubMed ID: 17404355
[No Abstract] [Full Text] [Related]
5. Current unsolved problems in diabetes management.
Fajans SS
Diabetes; 1972; 21(2 Suppl):678-84. PubMed ID: 5054334
[No Abstract] [Full Text] [Related]
6. Improved glycemic control and reduction of cardiometabolic risk factors in subjects with type 2 diabetes and metabolic syndrome treated with exenatide in a clinical practice setting.
Bhushan R; Elkind-Hirsch KE; Bhushan M; Butler WJ; Duncan K; Marrioneaux O
Diabetes Technol Ther; 2009 Jun; 11(6):353-9. PubMed ID: 19459763
[TBL] [Abstract][Full Text] [Related]
7. Prevention and early detection of vascular complications of diabetes.
Marshall SM; Flyvbjerg A
BMJ; 2006 Sep; 333(7566):475-80. PubMed ID: 16946335
[No Abstract] [Full Text] [Related]
8. Clinical review 51: Implications of the Diabetes Control and Complications Trial.
Eastman RC; Siebert CW; Harris M; Gorden P
J Clin Endocrinol Metab; 1993 Nov; 77(5):1105-7. PubMed ID: 8077299
[No Abstract] [Full Text] [Related]
9. Management of type 2 diabetes: summary of updated NICE guidance.
Home P; Mant J; Diaz J; Turner C;
BMJ; 2008 Jun; 336(7656):1306-8. PubMed ID: 18535074
[No Abstract] [Full Text] [Related]
10. Incretin-based therapy and the quest for sustained improvements in β-cell health.
Drucker DJ
Diabetes Care; 2011 Sep; 34(9):2133-5. PubMed ID: 21868783
[No Abstract] [Full Text] [Related]
11. A dramatic deterioration in diabetic retinopathy with improvement in glycated haemoglobin (HbA(1c)) on exenatide treatment.
Brooks AM; Lissett CA
Diabet Med; 2009 Feb; 26(2):190. PubMed ID: 19236627
[No Abstract] [Full Text] [Related]
12. Exenatide improves diastolic function and attenuates arterial stiffness but does not alter exercise capacity in individuals with type 2 diabetes.
Scalzo RL; Moreau KL; Ozemek C; Herlache L; McMillin S; Gilligan S; Huebschmann AG; Bauer TA; Dorosz J; Reusch JE; Regensteiner JG
J Diabetes Complications; 2017 Feb; 31(2):449-455. PubMed ID: 27884660
[TBL] [Abstract][Full Text] [Related]
13. Relationship of vascular complications and exenatide therapy failure in type 2 diabetic patients.
Blaslov K; Zibar K; Bulum T; Duvnjak L
Acta Clin Croat; 2013 Sep; 52(3):328-36. PubMed ID: 24558765
[TBL] [Abstract][Full Text] [Related]
14. Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice.
Vijan S; Stevens DL; Herman WH; Funnell MM; Standiford CJ
J Gen Intern Med; 1997 Sep; 12(9):567-80. PubMed ID: 9294791
[TBL] [Abstract][Full Text] [Related]
15. Reviewing statin therapy in diabetes--towards the best practise.
Matikainen N; Kahri J; Taskinen MR
Prim Care Diabetes; 2010 Apr; 4(1):9-15. PubMed ID: 20171948
[TBL] [Abstract][Full Text] [Related]
16. Type 2 diabetes and HbA1c targets.
Prescrire Int; 2008 Dec; 17(98):254. PubMed ID: 19425272
[TBL] [Abstract][Full Text] [Related]
17. An overview of what diabetes can do to your body (and what you can do to prevent it).
Gebel E
Diabetes Forecast; 2008 Dec; 61(12):45-6. PubMed ID: 19145747
[No Abstract] [Full Text] [Related]
18. [Late complications of diabetes--can we prevent them?].
Kappeler H
Schweiz Rundsch Med Prax; 1988 Mar; 77(9):222-9. PubMed ID: 3363266
[No Abstract] [Full Text] [Related]
19. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
Bajaj M; Jialal I
Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
[No Abstract] [Full Text] [Related]
20. [Insulin secretion is increased depending on glucose.. Metabolism regulation in type 2 diabetes mellitus over five paths].
MMW Fortschr Med; 2009 May; 151(19):50. PubMed ID: 19827447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
